Sit Vax and Relax: Updates on Respiratory Syncytial Virus Vaccines
Planned in cooperation with the Educational Steering Committee
ACPE Activity Number: 0204-0000-24-539-H06-P
Release Date: September 25, 2024
Expiration Date: September 25, 2027
Activity Type: Knowledge-based
CE Credits: 1.0 contact hour, (0.10 CEUs)
Activity Fee: Member – Free / Non-Member – Not Available
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
Activity Overview
In 2023, two new vaccines for prevention of respiratory syncytial virus (RSV) were approved by the FDA. This presentation will explore the latest data informing the use of RSV vaccines in clinical practice. It will discuss both maternal vaccinations and vaccination in older adult populations.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
This activity was planned to meet the educational needs of pharmacists who will care for patients eligible for the RSV vaccine in a commuity setting.
Learning Objectives
After completing this activity, the learner should be able to…
- Identify the differences between the two available RSV vaccines.
- Given a patient scenario, select the appropriate RSV vaccine if indicated to prevent RSV infection.
- Describe the integration of RSV vaccination into clinical practice.
Schedule of Activities
-
Introduction and Announcements
-
Presentation
-
Questions, Answers, and Discussion
Faculty
Michelle Patterson, PharmD, BCACP (Presenter)
Ambulatory Pharmacist Clinician
Penn Medicine Lancaster General Health
Department of Pharmacy and IV Solutions
Lancaster, PA
Margie E. Padilla, PharmD, CDCES, BCACP (Moderator)
Clinical Professor
University of Texas at El Paso School of Pharmacy
El Paso, Texas
Sarah R. Salazar, PharmD (Presenter)
PGY-2 Pharmacotherapy Resident
Clinical Instructor
University of Texas at El Paso School of Pharmacy
El Paso, Texas
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
-
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Methods and CE Requirements
This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.